- RON1.27bn
- RON1.10bn
- RON319.33m
Annual cashflow statement for Biofarm SA, fiscal year end - December 31st, RON millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 69.6 | 80.9 | 83.7 | 84.5 | — |
| Depreciation | |||||
| Non-Cash Items | 0.413 | 1.81 | -10.9 | -1.35 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -14.5 | -67.2 | -7.49 | -42.5 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 69.2 | 29 | 79.8 | 57.6 | — |
| Capital Expenditures | -21.5 | -30.1 | -29.8 | -23.4 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 22.3 | 2.51 | -83.8 | 36.2 | — |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.828 | -27.6 | -114 | 12.8 | — |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -20.7 | -22.5 | -28.2 | -29.2 | — |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 49.3 | -21.2 | -62.1 | 41.2 | — |